How the PEth Test Detects Alcohol in Your Blood

A PEth test measures phosphatidylethanol, an abnormal phospholipid that forms in red blood cell membranes only when alcohol is present in the body. Because PEth accumulates with repeated drinking and clears slowly, a single blood draw can reveal alcohol consumption patterns spanning roughly the previous three to four weeks. The test has gained traction in clinical, legal, and transplant settings because it is harder to game than older alcohol biomarkers and responds more directly to actual drinking.

How PEth Forms in Your Blood

PEth does not exist naturally in your body. It is created through an enzymatic reaction: when you drink, the enzyme phospholipase D, which normally breaks down cell-membrane phospholipids, instead swaps in ethanol as a substrate, producing phosphatidylethanol.¹ This reaction only happens in the presence of ethanol. No ethanol, no PEth. That one-to-one relationship between drinking and PEth formation is what makes the test so specific to alcohol use.

PEth embeds itself in red blood cell membranes, which is why the test uses whole blood rather than serum or plasma. Several molecular forms of PEth exist, each defined by the fatty acid chains attached, but two dominate in clinical testing: PEth 16:0/18:1 and PEth 16:0/18:2. Most labs report one or both of these as the primary measurement.

How Long PEth Stays Detectable

After a single drinking session, PEth levels rise within hours. In a controlled study with 16 volunteers who drank a single dose of alcohol, PEth 16:0/18:1 peaked within about eight hours and remained detectable for three to twelve days, with a half-life of roughly three days.² A separate clinical study measuring both major PEth forms after controlled alcohol exposure found a somewhat longer average half-life of about four to five days, though individual results ranged from one day to thirteen days.³

That wide individual range matters. Two people could drink the same amount, stop on the same day, and have very different PEth levels a week later. Factors like red blood cell turnover, hematocrit (the proportion of red cells in your blood), and individual enzyme activity all influence how quickly PEth clears. For repeated or heavy drinkers, PEth accumulates over weeks, which is why the test is often described as reflecting roughly a three-to-four-week drinking window. But after a single binge, the window is shorter.

Interpreting the Numbers

PEth results are reported as a concentration in blood, typically in nanograms per milliliter (ng/mL) or micromoles per liter (µmol/L). One widely referenced interpretive framework, published in a forensic sciences review, proposes three tiers: below 20 ng/mL suggests light or no consumption, 20 to 199 ng/mL indicates significant consumption, and 200 ng/mL or above points to heavy consumption.⁴

These tiers are useful as rough guideposts, but they are not standardized worldwide. Different labs and clinical contexts use slightly different cutoffs. A review of routine PEth analysis noted that values below roughly 20 to 35 ng/mL generally indicate sobriety or only low, occasional drinking, while values above around 200 ng/mL typically require regular heavy intake to reach.⁵ The lack of universally agreed-upon cutoff values remains one of the test’s main growing pains, and researchers have flagged this as something that needs to be resolved before truly standardized international guidelines can be adopted.⁶

How PEth Compares to Other Alcohol Biomarkers

If you have been tested for alcohol use before, you may have encountered CDT (carbohydrate-deficient transferrin), GGT (gamma-glutamyl transferase), or MCV (mean corpuscular volume). These older markers have been workhorses for decades, but they all have significant drawbacks. GGT and MCV can be elevated by liver disease, medications, or nutritional deficiencies that have nothing to do with drinking. CDT is more specific, but it can still be affected by certain liver conditions and is less sensitive to moderate drinking patterns.

PEth outperforms all of them on sensitivity. In a study of people undergoing occupational and pre-employment medical examinations, PEth detected far more cases of regular heavy drinking than CDT, GGT, or MCV. Every single person who tested positive on CDT also tested positive on PEth, but PEth caught many additional cases that CDT missed.⁷ A comparison in outpatient addiction treatment found the same pattern: PEth was the most sensitive biomarker for detecting ongoing drinking and relapses, outperforming CDT and complementing urine-based markers like EtG and EtS.⁸

Urine EtG (ethyl glucuronide) deserves separate mention because it occupies a different niche. EtG detects very recent alcohol use, typically within the past two to three days, and is extremely sensitive, sometimes picking up incidental alcohol exposure from foods or hygiene products. PEth and EtG are not really competitors; they answer different questions. EtG asks, “Did this person drink in the last couple of days?” PEth asks, “Has this person been drinking regularly over recent weeks?” Many clinical programs use both.

Can Anything Cause a False Positive?

One of the first concerns people have about PEth testing is whether non-beverage sources of alcohol, things like mouthwash, hand sanitizer, or cooking wine, could push them over the threshold. The evidence is reassuring on this front. A controlled study of regular alcohol-based mouthwash use confirmed that blood PEth concentrations did not reach the commonly used 20 ng/mL cutoff.⁹ Intensive use of alcohol-based hand sanitizer also failed to produce PEth levels above that same threshold.¹⁰

A broader study looked at a mix of incidental ethanol exposures across 30 participants. Two of them produced PEth levels at or above 20 ng/mL. One of those cases involved multiple daily ethanol exposure sources, including heavy vapor exposure, and the other involved a participant whose claim of total abstinence was doubted by the researchers. The study concluded that a PEth level of 20 ng/mL or above carries a strong presumption of beverage alcohol consumption, though intensive, unusual incidental exposures could modestly exceed it under rare circumstances.¹¹

So the 20 ng/mL cutoff is not perfectly bulletproof, but it holds up well in the vast majority of real-world situations. If you are not drinking but use mouthwash and hand sanitizer normally, a positive PEth result above that threshold is unlikely.

Does Light Drinking Show Up?

This is where things get nuanced. PEth correlates with how much and how often you drink, and a large population study of over 24,000 people confirmed a clear dose-response relationship: higher consumption meant higher PEth levels.¹² But at the low end, the test’s sensitivity drops considerably.

A study specifically designed to test low-dose detection had 75 participants drink about two standard drinks on three consecutive evenings. Using PEth 16:0/18:1 with a 10 ng/mL cutoff, only about a quarter tested positive after the first night, and just under half after the third night. At the more commonly used 20 ng/mL cutoff, PEth 16:0/18:1 exceeded that level in only five samples across the entire study. The researchers found that women were significantly more likely to test positive than men after consuming the same amount, likely because the same dose produces higher blood alcohol levels in women on average.¹³

The practical takeaway: if someone has a glass of wine once or twice a week, a PEth test using the standard 20 ng/mL cutoff will probably not flag them. The test is much better at catching moderate-to-heavy regular drinking than occasional light consumption. Some researchers have argued that the cutoff should be lowered for better detection of low-to-moderate drinking, but lowering it would also increase the chance of flagging incidental exposures, so there is a trade-off.

How the Blood Sample Is Collected

The traditional method is a standard venous blood draw into an EDTA tube. But PEth testing has moved toward dried blood spot (DBS) collection, which involves pricking your finger and applying a drop of blood to a special card or collection device. Multiple studies have confirmed that DBS results closely match liquid whole blood results. One validation using a Whatman filter card found essentially a one-to-one correlation between DBS and whole blood PEth values.¹⁴ A newer volumetric device (the TASSO-M20, designed for self-collection) also tracked closely with liquid blood, with PEth concentrations averaging only about five percent higher in dried samples.¹⁵

Volumetric DBS devices, which collect a fixed volume of blood, produce more precise measurements than traditional non-volumetric filter cards. One clinical comparison found a volumetric device had a coefficient of variation of under five percent, compared to about seventeen percent for a standard Whatman card.¹⁶ Dried samples can be mailed to a lab without cold-chain shipping, making remote and at-home testing feasible.

One technical wrinkle worth knowing: if a blood sample still contains active ethanol when it is applied to a DBS card, PEth can continue to form on the card during drying. Researchers demonstrated that blood from non-drinkers, spiked with ethanol and applied to DBS cards, generated measurable PEth concentrations within hours at room temperature.¹⁷ This means a blood sample taken while someone still has alcohol in their system could artificially inflate the PEth result. Labs and collection protocols account for this, but it is a reason why timing and proper handling matter.

PEth in Liver Transplant Evaluations

Transplant programs have become one of the most impactful settings for PEth testing. Patients awaiting a liver transplant are typically required to demonstrate sustained abstinence from alcohol, especially if their liver disease is alcohol-related. Self-reporting is unreliable in this population, and older biomarkers like CDT are complicated by the fact that advanced liver disease itself alters their levels.

PEth sidesteps many of those limitations. Even in people with liver disease, PEth showed high sensitivity (73 to 100 percent) and high specificity (90 to 96 percent) for detecting any recent alcohol use.¹⁸ A study of liver transplant recipients found PEth could detect moderate-to-heavy drinking that patients had not disclosed and that other tests had missed, making a case for routine post-transplant PEth monitoring.¹⁹

Routine pre-transplant PEth screening has also proven valuable. One center found that uniform PEth testing at initial transplant evaluation caught alcohol use that urine EtG testing alone would have missed and identified discrepancies with patients’ self-reports that changed clinical decisions.²⁰ Perhaps most striking, a study that tested all transplant candidates, not just those with alcohol-related liver disease, found a high rate of unreported drinking in the non-alcohol-related disease group as well, underscoring the value of universal screening.²¹

Legal and Forensic Uses

PEth testing increasingly shows up in legal contexts: child custody cases, drunk-driving license reinstatement, workplace safety investigations, and probation monitoring. A review of alcohol biomarkers in clinical and forensic settings noted PEth’s high specificity (48 to 89 percent) and sensitivity (88 to 100 percent) as a tool that complements the existing testing spectrum.²² The wide specificity range in that review reflects differing cutoffs and populations, but even at the lower end, the sensitivity stays high, meaning PEth rarely misses heavy drinkers.

For people involved in family court or custody disputes, a PEth test can serve as objective evidence of abstinence or ongoing use over recent weeks. Unlike a breathalyzer or even a urine EtG test, which only capture a snapshot of the last few hours or days, PEth provides a broader behavioral picture. Courts have increasingly accepted PEth results, though interpretation still requires someone familiar with the test’s nuances, especially around borderline values and individual variability.

Screening During Pregnancy

Alcohol use during pregnancy is notoriously underreported, and even small amounts carry risk for fetal development. PEth has emerged as a tool that can objectively identify prenatal alcohol exposure when self-reporting falls short. A systematic review of studies using PEth in maternal or neonatal blood found that PEth was consistently more sensitive than self-reports for identifying pregnant women who were actively drinking, with detection rates improving at higher levels of maternal alcohol intake.²³

The challenge is choosing the right cutoff. A study of 222 pregnant women in South Africa found that using a standard 20 ng/mL cutoff missed a substantial number of women who reported consuming alcohol during pregnancy. A lower threshold of 8 ng/mL captured more cases but inevitably reduced specificity.²⁴ Some researchers have proposed integrating PEth at a very low cutoff of 2 ng/mL into routine prenatal blood screening, with positive results triggering a follow-up clinical evaluation and retesting in two to four weeks.²⁵ This is far below the 20 ng/mL threshold used in most other clinical contexts, reflecting the unique stakes of fetal exposure and the goal of catching even low-level drinking.

Why Results Vary Between Individuals

One recurring theme across PEth research is inter-individual variability. Two people can drink the same amount over the same period and produce noticeably different PEth levels. Part of the reason is hematocrit: PEth lives in red blood cells, so someone with a higher proportion of red cells in their blood will concentrate more PEth per unit of whole blood. Research on dried blood spot methods has confirmed a linear increase in PEth concentration with rising hematocrit, and some labs now apply corrections for this.²⁶

Body composition and sex also play a role. As the low-dose drinking study mentioned earlier showed, women tended to produce higher PEth concentrations than men after the same dose, likely because of differences in body water distribution and alcohol metabolism. Individual variation in the phospholipase D enzyme that catalyzes PEth formation may also contribute, though this is less well characterized.

For practical purposes, this variability means a PEth result is best interpreted as part of a pattern. A single borderline value in isolation tells you less than a trend over multiple tests, and clinical decision-making should not hinge entirely on one number near a cutoff boundary.

Ethical Questions in Primary Care

As PEth testing moves beyond specialized transplant and forensic settings into general primary care, new ethical questions are surfacing. A qualitative study of general practitioners in Scandinavia found that while doctors saw PEth as a game changer for identifying hazardous drinking, they also grappled with dilemmas around consent and disclosure. When a routine blood panel reveals high PEth, what are the doctor’s obligations? Should patients be informed before the test that PEth will be included? What happens when a high result triggers legal or occupational consequences the patient did not anticipate?²⁷

These questions do not have settled answers yet. Unlike testing for illicit drugs, where informed consent protocols are well established, PEth testing has moved into clinical practice faster than the ethical and legal frameworks around it. If you are asked to take a PEth test, it is reasonable to ask who will see the results, what cutoff will be used, and whether a positive result carries any consequences beyond your medical care.